AdaptHealth (NASDAQ:AHCO) Price Target Lowered to $13.00 at Truist Financial

AdaptHealth (NASDAQ:AHCO) had its target price decreased by analysts at Truist Financial from $14.00 to $13.00 in a research note issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. Truist Financial’s price target would indicate a potential upside of 43.65% from the stock’s current price.

Several other equities research analysts have also recently weighed in on AHCO. UBS Group lowered their price objective on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a research report on Thursday, February 13th. Canaccord Genuity Group raised their price objective on shares of AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. Royal Bank of Canada dropped their target price on shares of AdaptHealth from $14.00 to $13.00 and set an “outperform” rating for the company in a research report on Thursday. Finally, Robert W. Baird increased their price target on AdaptHealth from $14.00 to $16.00 and gave the company an “outperform” rating in a research note on Thursday, February 27th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $13.40.

AdaptHealth Stock Performance

Shares of AHCO traded up $0.47 during trading hours on Monday, reaching $9.05. 692,554 shares of the company traded hands, compared to its average volume of 1,272,899. AdaptHealth has a 1-year low of $7.11 and a 1-year high of $11.90. The stock has a market cap of $1.22 billion, a P/E ratio of -5.48, a price-to-earnings-growth ratio of 1.08 and a beta of 1.64. The stock’s fifty day moving average is $9.29 and its 200 day moving average is $9.73. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24.

Institutional Trading of AdaptHealth

Large investors have recently modified their holdings of the stock. Barclays PLC lifted its position in AdaptHealth by 361.3% during the third quarter. Barclays PLC now owns 181,240 shares of the company’s stock worth $2,034,000 after purchasing an additional 141,949 shares during the period. Franklin Resources Inc. lifted its holdings in shares of AdaptHealth by 20.2% during the 3rd quarter. Franklin Resources Inc. now owns 65,601 shares of the company’s stock worth $737,000 after acquiring an additional 11,037 shares during the period. JPMorgan Chase & Co. boosted its position in shares of AdaptHealth by 73.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 191,833 shares of the company’s stock worth $2,154,000 after acquiring an additional 81,097 shares in the last quarter. Reinhart Partners LLC. increased its stake in AdaptHealth by 1.1% in the fourth quarter. Reinhart Partners LLC. now owns 6,266,854 shares of the company’s stock valued at $59,660,000 after acquiring an additional 68,212 shares during the last quarter. Finally, Moody National Bank Trust Division raised its position in AdaptHealth by 31.5% during the fourth quarter. Moody National Bank Trust Division now owns 151,170 shares of the company’s stock valued at $1,439,000 after purchasing an additional 36,212 shares in the last quarter. 82.67% of the stock is owned by institutional investors and hedge funds.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.